Label: BRONTUSS DX- dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 17, 2009

If you are a consumer or patient please visit this version.

  • Drug Facts

    Active ingredients                             Purpose
    (in each 5 mL teaspoonful)
    Dextromethorphan Hydrobromide 20 mg...... Antitussive
    Guaifenesin 200 mg................................ Expectorant
    Phenylephrine Hydrochloride 10 mg..........Decongestant
  • Uses

    temporarily relieves these symptoms, due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
    • cough due to minor throat and bronchial irritation
    • helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
    • nasal congestion
    • reduces swelling of nasal passages
  • Warnings

    Do not exceed recommended dosage.

    Do not use this product

    • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product

    Ask a doctor before use if you have

    • a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema
    • a cough that occurs with too much phlegm (mucus)
    • heart disease
    • high blood pressure
    • thyroid disease
    • diabetes
    • trouble urinating due to an enlarged prostate gland

    Stop use and ask a doctor if

    • nervousness, dizziness, or sleeplessness occur
    • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache. These could be signs of a serious condition.
    • new symptoms occur

    If pregnant or breast-feeding,

    ask a health professional before use.

    Keep out of reach of children.

    In case of accidental overdose, seek professional help or contact a Poison Control Center immediately.
  • Directions

    Do not exceed recommended dosage.
    Adults and Children 12 years of age and older:             
    2 teaspoonfuls (10mL) every 6 hours, not to exceed 4 doses in a 24 hour period.
    Children 6 to under 12 years of age:
    1 teaspoonful (5 mL) every 6 hours, not to exceed 4 doses in a 24 hour period.
    Children under 6 years of age:
    Not recommended for use.

  • Other information

    Store at 59o-86oF (15o-30oC)
  • Inactive ingredients

    cherry flavor, citric acid, maltitol, propylene glycol, purified water, sodium citrate, sodium saccharin, and sorbitol.
  • Questions? Comments?

    Serious side effects associated with this product may be reported to this number.
    Call (787)832-6645
    Operation Hours: Monday - Friday, 8 A.M. to 4 P.M. Atlantic Standard Time (AST)
    portalpharmaceutical@gmail.com

    Manufactured for:

    Portal Pharmaceutical
    Mayaguez, PR 00680

    Rev. 10/09
  • PRODUCT PACKAGING:

    The packaging below represents the labeling currently used:

    Principal Display Panel and Side Panel for 118mL Label:

    NDC 49963-913-04

    Brontuss
    DX

    Antitussive / Expectorant
    Decongestant

    Each teaspoonful (5 mL) for oral administration contains:
    Dextromethorphan HBr.............. 20 mg
    Guaifenesin.............................200 mg
    Phenylephrine HCl.................... 10 mg


    Dye Free - Sugar Free

    Alcohol Free - Gluten Free

    4 oz. (118 mL)

    Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.

    Supplied in a tight, light-resistant container with a child-resistant cap.

    Manufactured for:
    Portal Pharmaceutical
    Mayaguez, PR 00680

    Rev. 10/09

    Principal Display Panel and Side Panel for 15 mL Label:

    NDC 49963-913-15

    Brontuss
    DX

    Antitussive / Expectorant
    Decongestant

    Each teaspoonful (5 mL) for oral administration contains:
    Dextromethorphan HBr.......... 20 mg
    Guaifenesin........................ 200 mg
    Phenylephrine HCl................ 10 mg

    Dye Free / Sugar Free
    Alcohol Free / Gluten Free

    15 mL (1/2 fl oz)

    Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing.
    Supplied in a tight, light-resistant container with a child-resistant cap.

    Professional Sample:

    Not For Sale

    Manufactured for:
    Portal Pharmaceutical
    Mayaguez, PR 00680

    Rev. 10/09

    Brontuss DX Packaging

    Brontuss DX Packaging

    Brontuss DX Packaging

    Brontuss DX Packaging

  • INGREDIENTS AND APPEARANCE
    BRONTUSS  DX
    dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49963-913
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Dextromethorphan Hydrobromide (UNII: 9D2RTI9KYH) (Dextromethorphan - UNII:7355X3ROTS) Dextromethorphan Hydrobromide20 mg  in 5 mL
    Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ) Guaifenesin200 mg  in 5 mL
    Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV) Phenylephrine Hydrochloride10 mg  in 5 mL
    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorCHERRYImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49963-913-04118 mL in 1 BOTTLE
    2NDC:49963-913-1515 mL in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34111/24/2009
    Labeler - Portal Inc. (831005199)